|
2024
|
Invention
|
Composition for nasal administration. The present invention addresses the problem of providing a ... |
|
|
Invention
|
Composition for use in vaccine. The present invention relates to a composition for use in vaccine... |
|
2023
|
Invention
|
Stabilized vlp vaccine. The present invention can provide an Enterovirus-derived VLP vaccine that... |
|
|
Invention
|
Composition suitable for use as rs virus vaccine. The purpose of the present invention is to prov... |
|
|
Invention
|
Fusion protein containing receptor binding domain of parvovirus, and anti-parvovirus vaccine comp... |
|
|
Invention
|
Fusion protein and vaccine. The present invention provides a fusion protein which is useful as a ... |
|
|
Invention
|
Adjuvant. To provide an adjuvant containing lipid particles having a higher immune response induc... |
|
2022
|
Invention
|
Betacoronavirus attenuated strain. The purpose of the present invention is to provide a strain th... |
|
2021
|
Invention
|
Fusion protein and vaccine.
The present invention provides a new component that is useful as a S... |
|
|
Invention
|
Fusion protein and vaccine. The present invention provides a new component that is useful as a SA... |
|
|
Invention
|
Temperature-sensitive betacoronavirus strain and vaccine.
Provided is a strain that is effective... |
|
|
Invention
|
Beta coronavirus cold acclimatized strain and vaccine.
Strains that is effective as the active c... |
|
|
Invention
|
Beta coronavirus cold acclimatized strain and vaccine. A strain that is effective as the active c... |
|
|
Invention
|
Temperature-sensitive betacoronavirus strain and vaccine. Provided is a strain that is effective ... |
|
|
Invention
|
Knockout coronavirus. The present invention provides a corona virus that has restricted replicati... |
|
|
Invention
|
Preventive agent for japanese encephalitis and japanese encephalitis vaccine. The present inventi... |
|
2019
|
Invention
|
Botulinum toxin producing method. Provided is a botulinum toxin producing method which is simple ... |
|
|
Invention
|
Construction of cho cell line expressing vlp. [Problem] To provide a CHO cell line for producing ... |
|
|
Invention
|
Human norovirus-like particle and use thereof. The present invention addresses the problem of pro... |
|
|
Invention
|
Method for culturing influenza virus. Provided is a method for culturing the influenza virus usin... |
|
|
Invention
|
Aluminum phosphate compound.
The present invention provides a substance which is useful as a car... |
|
|
Invention
|
Aluminum phosphate compound. The present invention provides a substance which is useful as a carr... |
|
|
Invention
|
Japanese-encephalitis-vaccine-containing microneedle array. The present invention addresses the p... |
|
|
Invention
|
Human norovirus proliferation. in vitroin vitro, the method avoiding the moral issues involved wi... |
|
|
Invention
|
Enterovirus vaccine. The present invention provides a vaccine for enteroviruses. In view of the s... |
|
|
Invention
|
Medium for culturing pneumococcal samples.
An object of the present invention is to provide a te... |
|
|
Invention
|
Multi-layer culture vessel observation system, carriage device, and multi-layer culture vessel ob... |
|
2018
|
Invention
|
Method for gradual construction of reassortant influenza virus.
Provided is a production method ... |
|
|
Invention
|
Method for gradual construction of reassortant influenza virus. Provided is a method for construc... |
|
|
Invention
|
Method for producing sterilized viscous base and method for producing medicinal preparation. Prov... |
|
|
P/S
|
Pharmaceutical preparations; biological preparations for
medical purposes; vaccines. |
|
|
Invention
|
Polyvalent vaccine. The present invention addresses the problem of providing a polyvalent vaccine... |
|
|
Invention
|
Lipid a. Provided is lipid A, which has a novel structure. More specifically, provided is lipid A... |
|
2017
|
Invention
|
Dendritic-cell-targeted peptide, fusion peptide utilizing said peptide, and vaccine utilizing sai... |
|
|
Invention
|
Adjuvant composition. The purpose of the present invention is to provide: an adjuvant composition... |
|
|
Invention
|
Reassortant influenza virus production method. Provided is a method of producing reassortant infl... |
|
|
Invention
|
Reassortant influenza virus production method. Provided is a method for producing a reassortant i... |
|
|
Invention
|
Method for culturing mdck cells.
The present invention relates to a cloned MDCK cell showing an ... |
|
|
Invention
|
Method for culturing mdck cells. The present invention pertains to: cloned MDCK cells which exhib... |
|
|
Invention
|
Purification method for target protein. The present invention relates to a purification method fo... |
|
2016
|
Invention
|
Vaccine pharmaceutical composition for oral administration and method for manufacturing vaccine p... |
|
|
Invention
|
Method for measuring complement-dependent bactericidal function with respect to pneumococci.
The... |
|
|
Invention
|
Method for measuring complement-dependent bactericidal function with respect to pneumococci. The ... |
|
|
Invention
|
Human herpes virus 6b antigen composition. Provided is an antigen composition, pertaining to huma... |
|
|
Invention
|
Cells for influenza virus production. The invention pertains to MDCK cells that can be used suita... |
|
|
Invention
|
Influenza virus-neutralizing antibody and screening method therefor. Provided is an anti-influenz... |
|
2015
|
Invention
|
Adjuvant obtained from layered double hydroxide. The present invention relates to an adjuvant, wh... |
|
|
Invention
|
Nerve elongation promoter and elongation inhibitor.
The invention provides agents that promote o... |
|
2014
|
Invention
|
Anti-influenza virus neutralizing antibody.
It is an object of the present invention to provide ... |
|
2011
|
P/S
|
Pharmaceutical, veterinary and sanitary preparations, other
than pyrethrum coils and other anti-... |
|
|
P/S
|
Pharmaceutical, veterinary and sanitary preparations (other than pyrethrum coils and other anti-m... |
|
1990
|
P/S
|
Pharmaceutical preparations, diagnostic preparations and biological products for human and animal... |
